These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3168291)

  • 1. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis.
    Gilljam H; Andersson O; Ellin A; Robertson B; Strandvik B
    Clin Chim Acta; 1988 Aug; 176(1):29-37. PubMed ID: 3168291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis.
    Gilljam H; Strandvik B; Ellin A; Wiman LG
    Scand J Clin Lab Invest; 1986 Oct; 46(6):511-8. PubMed ID: 3775237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.
    Girod S; Galabert C; Lecuire A; Zahm JM; Puchelle E
    Pediatr Pulmonol; 1992 May; 13(1):22-7. PubMed ID: 1589308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis.
    Slomiany A; Murty VL; Aono M; Snyder CE; Herp A; Slomiany BL
    Biochim Biophys Acta; 1982 Jan; 710(1):106-11. PubMed ID: 7055590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis.
    Seidl E; Kiermeier H; Liebisch G; Ballmann M; Hesse S; Paul-Buck K; Ratjen F; Rietschel E; Griese M
    J Cyst Fibros; 2019 Nov; 18(6):790-795. PubMed ID: 31029606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high lipid content of respiratory mucins in cystic fibrosis is related to infection.
    Houdret N; Perini JM; Galabert C; Scharfman A; Humbert P; Lamblin G; Roussel P
    Biochim Biophys Acta; 1986 Jan; 880(1):54-61. PubMed ID: 3942779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
    Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
    Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis.
    Galabert C; Jacquot J; Zahm JM; Puchelle E
    Clin Chim Acta; 1987 Apr; 164(2):139-49. PubMed ID: 3594907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular and lipid constituents of bronchial epithelial mucus.
    Reid LM; Bhaskar KR
    Symp Soc Exp Biol; 1989; 43():201-19. PubMed ID: 2701477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
    Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
    Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
    Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
    J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracheobronchial surface active material in cystic fibrosis.
    Griese M; Duroux A; Schams A; Lenz AG; Kleinsasser N
    Eur J Med Res; 1997 Mar; 2(3):114-20. PubMed ID: 9113501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure of the bronchial epithelium in adult patients with cystic fibrosis.
    Gilljam H; Motakefi AM; Robertson B; Strandvik B
    Eur J Respir Dis; 1987 Sep; 71(3):187-94. PubMed ID: 3678420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased bronchial chloride concentration in cystic fibrosis.
    Gilljam H; Ellin A; Strandvik B
    Scand J Clin Lab Invest; 1989 Apr; 49(2):121-4. PubMed ID: 2520363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid composition of milk from mothers with cystic fibrosis.
    Bitman J; Hamosh M; Wood DL; Freed LM; Hamosh P
    Pediatrics; 1987 Dec; 80(6):927-32. PubMed ID: 3684406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.
    Gunasekara L; Al-Saiedy M; Green F; Pratt R; Bjornson C; Yang A; Michael Schoel W; Mitchell I; Brindle M; Montgomery M; Keys E; Dennis J; Shrestha G; Amrein M
    J Cyst Fibros; 2017 Sep; 16(5):565-572. PubMed ID: 28599957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction and loss of bronchial cartilage in cystic fibrosis.
    Ogrinc G; Kampalath B; Tomashefski JF
    Hum Pathol; 1998 Jan; 29(1):65-73. PubMed ID: 9445136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray microanalysis of goblet cells in bronchial epithelium of patients with cystic fibrosis.
    Roomans GM; von Euler AM; Müller RM; Gilljam H
    J Submicrosc Cytol; 1986 Jul; 18(3):613-5. PubMed ID: 3746973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid composition of sputum from patients with asthma and patients with cystic fibrosis.
    Sahu S; Lynn WS
    Inflammation; 1978 Mar; 3(1):27-36. PubMed ID: 581080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis.
    Hauber HP; Tulic MK; Tsicopoulos A; Wallaert B; Olivenstein R; Daigneault P; Hamid Q
    Can Respir J; 2005; 12(1):13-8. PubMed ID: 15776129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.